Drug treatment is an adjunct when dietary restrictions on saturated fat and cholesterol and other non-pharmacological measures are not effective enough.
Prevention of cardiovascular complications:
Reduces the risk of myocardial infarction (MI).
Reduces the risk of revascularization.
Reduce the risk of cardiovascular mortality by not increasing mortality from non-cardiovascular causes.
In patients with clinically evident cardiovascular disease, Pravastatin is indicated to:
Reduce your risk of death by reducing deaths from coronary heart disease.
Reduces the risk of myocardial infarction (MI).
Reduces the risk of revascularization.
Reduce the risk of stroke and ischemic attack (TIA).
Slows the progression of coronary atherosclerosis.
Drug treatment is an adjunct when dietary restrictions on saturated fat and cholesterol and other non-pharmacological measures are not effective enough.
Prevention of cardiovascular complications:
Reduces the risk of myocardial infarction (MI).
Reduces the risk of revascularization.
Reduce the risk of cardiovascular mortality by not increasing mortality from non-cardiovascular causes.
In patients with clinically evident cardiovascular disease, Pravastatin is indicated to:
Reduce your risk of death by reducing deaths from coronary heart disease.
Reduces the risk of myocardial infarction (MI).
Reduces the risk of revascularization.
Reduce the risk of stroke and ischemic attack (TIA).
Slows the progression of coronary atherosclerosis.